The Journal of Korean Diabetes

Opinion
Glucagon-Like Peptide-1수용체작용제의 전 세계적 품절 사태: 이동원; J Korean Diabetes. 2024;25(1):1-3.

The global shortage of glucagon-like peptide-1 (GLP-1) receptor agonists, which are highly sought after as treatments for type 2 diabetes and obesity, is increasing. This deficit is attributed to the...

Statement
조기 발병 2형당뇨병, 그 관리전략: 김진화; J Korean Diabetes. 2024;25(1):4-8.

Early-onset type 2 diabetes is experiencing a rapid global increase, coinciding with the escalating rates of obesity. In contrast to diagnoses later in life, an earlier diagnosis is associated with...

Focused Issue
당뇨병과 SGLT2억제제: 지금까지의 여정과 향후 과제: 김지윤, 김신곤; J Korean Diabetes. 2024;25(1):9-15.

Sodium glucose cotransporter 2 (SGLT2) inhibitors have emerged as powerful medications in the past decade. Numerous clinical trials have reported their cardio-renal protective effects and associated reductions in mortality. The...

Focused Issue
만성콩팥병과 SGLT2억제제: 고은실, 정성진; J Korean Diabetes. 2024;25(1):16-25.

Sodium glucose cotransporter 2 (SGLT2) inhibitors were initially developed to enhance glycemic control in diabetic patients, but they have emerged as a promising treatment for individuals with chronic kidney disease...

Focused Issue
심혈관질환과 SGLT2억제제: 박진주; J Korean Diabetes. 2024;25(1):26-34.

Sodium glucose cotransporter 2 (SGLT2) inhibitors, initially designed for type 2 diabetes management, have exhibited consistent efficacy across the cardiovascular disease continuum. Their benefits are experienced by patients with cardiovascular...

Information Desk
당뇨병발궤양 예방과 궤양 전 징후들의 치료: 손지원; J Korean Diabetes. 2024;25(1):35-41.

Diabetes is one of the most prevalent chronic conditions and is expected to affect nearly 800 million people worldwide by 2045. Diabetes entails many complications; diabetic foot is among the...

Information Desk
2023 당뇨병 식품교환표 개정과 식사계획을 위한 활용 지침: 임정현; J Korean Diabetes. 2024;25(1):42-51.

Nutrition therapy is plays a pivotal role in diabetes prevention and blood glucose control among diabetics. The contents of the revision of the food exchange lists are as follows. First,...

Information Desk
노인당뇨병 환자의 퇴원계획: 조선희; J Korean Diabetes. 2024;25(1):52-56.

As the elderly population increases, the importance of treatment and management of elderly diabetic patients is also growing. Diabetes is a disease for which self-management is important; diabetes educators form...

Current Issue: Volume 25(1); Mar 2024

Opinion

Glucagon-Like Peptide-1수용체작용제의 전 세계적 품절 사태: 이동원; J Korean Diabetes. 2024;25(1):1-3. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.1

Statement

조기 발병 2형당뇨병, 그 관리전략: 김진화; J Korean Diabetes. 2024;25(1):4-8. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.4

Focused Issues

당뇨병과 SGLT2억제제: 지금까지의 여정과 향후 과제: 김지윤, 김신곤; J Korean Diabetes. 2024;25(1):9-15. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.9
Cited By 3

만성콩팥병과 SGLT2억제제: 고은실, 정성진; J Korean Diabetes. 2024;25(1):16-25. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.16
Cited By 1

심혈관질환과 SGLT2억제제: 박진주; J Korean Diabetes. 2024;25(1):26-34. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.26

Information Desks

당뇨병발궤양 예방과 궤양 전 징후들의 치료: 손지원; J Korean Diabetes. 2024;25(1):35-41. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.35

2023 당뇨병 식품교환표 개정과 식사계획을 위한 활용 지침: 임정현; J Korean Diabetes. 2024;25(1):42-51. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.42
Cited By 2

노인당뇨병 환자의 퇴원계획: 조선희; J Korean Diabetes. 2024;25(1):52-56. Published online March 31, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.1.52

Volume 25, No. 1

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

4,170	Community-Based Intervention for Elderly Patients with Diabetes Mellitus: Assessing the Effectiveness of a YouTube Self-Education Program during the Global COVID-19 Pandemic
6,059	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
5,004	2023 Clinical Practice Guidelines for Diabetes
3,750	Assessment of Insulin Secretion and Insulin Resistance
1,014	Initial Evaluation of Patients with Diabetes Mellitus according to Clinical Guidelines

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2025 by Korean Diabetes Association. All rights reserved.

prev

next